Finance

Lists
Why is GMED down 2,70%?
Dive Deeper
GMED:NYSE
Globus Medical Inc
76,71 $
-2,70%
(-2,13) 1D
76,71 $
0,00% (0,00)
After hours
Closed: 16 қаз., 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMED...
Open
79,35 $
High
79,95 $
Low
76,49 $
Mkt. cap
10,30 млрд
Avg. vol.
1,58 млн
Volume
1,94 млн
P/E ratio
19,61
52-wk high
101,40 $
52-wk low
58,51 $
EPS
3,91 $
Beta
0,96
Shares outstanding
112,62 млн
No. of employees
6 мың
Open
79,35 $
High
79,95 $
Low
76,49 $
Mkt. cap
10,30 млрд
Avg. vol.
1,58 млн
Volume
1,94 млн
P/E ratio
19,61
52-wk high
101,40 $
52-wk low
58,51 $
EPS
3,91 $
Beta
0,96
Shares outstanding
112,62 млн
No. of employees
6 мың
News stories
From web sources and news partners
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc
CEOKeith Pfeil
Employees6 мың
Founded2003
Headquarters-
SectorMedical device
Analyst ratings
Based on 13 analysts giving stock ratings to GMED in the past 3 months
Buy
Buy
9
Hold
4
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for GMED in the last 3 months.
Highest
Current 76,71 $
117,00 $ (+52,52%)
Average
98,75 $ (+28,73%)
Lowest
82,00 $ (+6,90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Reiterated
85,00 $
+10,8%
10/07/2026
Kendall Au
RBC Capital
Buy
Maintained
85,00 $
+10,8%
10/01/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
85,00 $
+10,8%
10/01/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
09/18/2026
Vik Chopra
BMO Capital
Buy
Maintained
94,00 $
+22,5%
08/27/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
115,00 $
+49,9%
08/28/2026
Keith Hinton
Freedom Capital Markets
Hold
Maintained
87,00 $
+13,4%
08/27/2026
Travis Steed
Bank of America Securities
Buy
Maintained
106,00 $
+38,2%
08/19/2026
Richard Newitter
Truist Financial
Buy
Reiterated
100,00 $
+30,4%
08/07/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
100,00 $
+30,4%
08/07/2026
David Saxon
Needham
Buy
Reiterated
117,00 $
+52,5%
08/07/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
115,00 $
+49,9%
08/06/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
99,00 $
+29,1%
08/07/2026
Mathew Blackman
TD Cowen
Buy
Maintained
115,00 $
+49,9%
08/06/2026
Unknown Analyst
UBS
Hold
Initiated
82,00 $
+6,9%
07/28/2026
Patrick Wood
UBS
Hold
Initiated
82,00 $
+6,9%
07/28/2026
Unknown Analyst
BMO Capital
Buy
Initiated
94,00 $
+22,5%
07/09/2026
Matt Miksic
Barclays
Buy
Maintained
123,00 $
+60,3%
05/11/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
115,00 $
+49,9%
05/08/2026
Last report
2026 ж. 06 там.
Fiscal period
Q2 2026
1,34 $ / 1,10 $
+21,91%beat
Revenue / Est. (USD)
789,61 млн / 782,98 млн
+0,85%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
769,05 млн
826,42 млн
759,85 млн
789,61 млн
Cost of goods sold
246,13 млн
254,62 млн
234,07 млн
241,44 млн
Cost of revenue
246,13 млн
254,62 млн
234,07 млн
241,44 млн
Research and development expenses
38,07 млн
36,16 млн
36,51 млн
36,32 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
284,19 млн
304,78 млн
297,77 млн
286,82 млн
Operating expense
352,10 млн
370,30 млн
363,81 млн
352,70 млн
Total operating expenses
598,23 млн
624,93 млн
597,87 млн
594,14 млн
Operating income
170,82 млн
201,49 млн
161,98 млн
195,47 млн
Other non operating income
1,54 млн
865,00 м.
2,25 млн
1,17 млн
EBT including unusual items
143,99 млн
169,23 млн
157,07 млн
189,82 млн
EBT excluding unusual items
173,65 млн
198,52 млн
167,55 млн
202,85 млн
Income tax expense
25,03 млн
28,64 млн
32,77 млн
38,25 млн
Effective tax rate
17,38%
16,92%
20,86%
20,15%
Other operating expenses
-
-
-
-
Net income
118,97 млн
140,59 млн
124,30 млн
151,57 млн
Net profit margin
15,47%
17,01%
16,36%
19,20%
Earnings per share
1,18
1,28
1,12
1,34
Interest and investment income
1,46 млн
3,31 млн
5,43 млн
7,07 млн
Interest expense
-
-
-
-
Net interest expenses
1,46 млн
3,31 млн
5,43 млн
7,07 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
242,02 млн
270,31 млн
231,93 млн
265,05 млн
Gain or loss from assets sale
2,31 млн
4,09 млн
2,45 млн
3,11 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары